AFT Pharmaceuticals to raise $33.2 mln in IPO at $2.80 a share, list on NZX, ASX

AFT Pharmaceuticals to raise $33.2 mln in IPO at $2.80 a share, list on NZX, ASX
Jonathan Underhill
Nov. 26 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based company whose products include Maxigesic pain medication and Maxiclear PE nasal decongestant, plans to list on the NZX and ASX next month after it has raised $33.2 million in an initial public offering. The company set the price of 11.9 million shares to be offered at $2.80 apiece, following an institutional bookbuild, valuing AFT at $269 million, according to a draft company statement. The IPO includes $30.2 million of new capital to fund growth at AFT, while the trustees of t...